Study #2018-0706
Strategies for Persistent Agitated Delirium in Palliative Care
MD Anderson Study Status
Not Accepting
Treatment Agent
Haloperidol, Lorazepam
Description
This phase II/IIII trial studies how well haloperidol and lorazepam work in controlling symptoms of persistent agitated delirium in patients with cancer that has spread to other places in the body undergoing palliative care. Haloperidol and lorazepam may help in controlling symptoms of agitated delirium in patients with cancer and may lessen any distress that their caregivers may be experiencing.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm
Study phase:
Phase II/III
Physician name:
David Hui
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.